14 September 2022 - The US Congress has just approved the Inflation Reduction Act of 2022, which includes a provision that Medicare be allowed to negotiate drug prices with pharmaceutical companies.
The first steps will not happen until 2026, when 10 of the most popular drugs will be subject to drug price negotiation. Additional provisions of the bill will make key changes to reimbursement to patients enrolled in Medicare Part D.